Ideas

Natural product-based therapy for TIIDM: A pharmaceutical mixture encompassing Scopolin, Spermidine, Curcumin, and Fucosterol (SSCF) augments the expression of FGF19 and FGF1,   attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIIDM via up regulation of its target gene, 30/October/2017, 9.20 am
Natural product-based therapy for TIIDM: A pharmaceutical mixture encompassing Scopolin, Spermidine, Curcumin, and Fucosterol (SSCF) augments the expression of FGF19 and FGF1,   attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIIDM via up regulation of its target gene, 30/October/2017, 9.20 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, Seattle, Washington, USA shows that Central injection of FGF1 induces sustained…

read more

Molecular therapy for attenuating  pathogenesis associated with  Myocardial infarction: Glimepiride, an anti-diabetic medication, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 30/October/2017, 9.09 am
Molecular therapy for attenuating  pathogenesis associated with  Myocardial infarction: Glimepiride, an anti-diabetic medication, decreases GM-CSF (Granulocyte-macrophage colony-stimulating factor) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits left ventricular rupture, and promotes heart healing via up regulation of its target gene, 30/October/2017, 9.09 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A recent study from Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; and Center for Systems Biology, Massachusetts General Hospital…

read more

Natural product-derived therapy for anxiety and depression:  Cinnamon essential oil decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 30/October/2017, 8.55 am
Natural product-derived therapy for anxiety and depression:  Cinnamon essential oil decreases PHF8 levels, increases the expression of serotonin receptors Htr1a and Htr2a, and promotes resistance to stress-induced -anxiety and -depression via down regulation of its target gene, 30/October/2017, 8.55 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say: A study from Department of Molecular Biology, Cancer Center and Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA; Department of Stem Cell and…

read more

Natural product-derived therapy for Myocardial Infarction: Kaempferol-3-O-rutinoside, isolated from Solidago virgaurea – European Goldenrod, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up regulation of PNUTS, 29/October/2017,  9.16 am
Natural product-derived therapy for Myocardial Infarction: Kaempferol-3-O-rutinoside, isolated from Solidago virgaurea – European Goldenrod, inhibits DNA damage responses, induces telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up regulation of PNUTS, 29/October/2017,  9.16 am 960 720 Dr Boomi's Genom-2-Discovery Center

What they say:  A recent study from the Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Frankfurt, Germany shows that “MicroRNA-34a regulates cardiac ageing and function.” This study was published, in the 7 March  2013 issue of Nature,  by Prof Dimmler, Boon, and others. What we…

read more

Molecular therapy for Glaucoma: Rivoglitazone, an antihyperglycemic drug, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma via down regulation of its target gene, 29/October/2017, 8.01 am
Molecular therapy for Glaucoma: Rivoglitazone, an antihyperglycemic drug, increases Nmnat1 expression, increases NAD+ levels, improves neuronal dysfunction, and protects against glaucoma via down regulation of its target gene, 29/October/2017, 8.01 am 960 720 Dr Boomi's Genom-2-Discovery Center

Introduction: What they say A study from the The Jackson Laboratory, Bar Harbor, ME 04609, USA; Department of Ophthalmology, Tufts University of Medicine, Boston, MA 02111, USA; The Howard Hughes…

read more

Natural product-based therapy for Deafness: A therapeutic mix encompassing Lutein, Puerarin, Cholecalciferol  and DIM (LPCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  and improves hearing loss via up regulation of its target genes, 29/October/2017, 7.50 am
Natural product-based therapy for Deafness: A therapeutic mix encompassing Lutein, Puerarin, Cholecalciferol  and DIM (LPCAD)  increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration,  and improves hearing loss via up regulation of its target genes, 29/October/2017, 7.50 am 960 720 Dr Boomi's Genom-2-Discovery Center

What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: A therapeutic mix encompassing Lutein, Puerarin, Cholecalciferol  and DIM (LPCAD)  increases the expression of ATG5…

read more
Start Typing